Autori: Peters Solange
| Naslov | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article) |
| Autori | Peters Solange ... Andric Zoran G ... (broj koautora 26) |
| Info | NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+ |
| Projekat | F. Hoffmann-La Roche, Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
